The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling

Journal of Hepatology

Volumn 64, Issue 6, 2016, Pages 1416-1427

  Bottazzi, Barbara ^a   Inforzato, Antonio ^a,b   Messa, Massimo ^b   Barbagallo, Marialuisa ^a   Magrini, Elena ^a   Garlanda, Cecilia ^a   Mantovani, Alberto ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Clinical biomarker; Inflammation; Innate immunity; Pattern recognition molecules; Pentraxin

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID; C REACTIVE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; PENTRAXIN 3; SERUM AMYLOID P; TUMOR NECROSIS FACTOR;

ACIDIFICATION; ACIDITY; BONE MARROW CELL; CELL DIFFERENTIATION; COMPLEMENT SYSTEM; ENDOTHELIUM CELL; FIBROSIS; GENE CONTROL; HUMAN; INFECTION RESISTANCE; INFLAMMATION; INNATE IMMUNITY; LIVER; LIVER CELL; MONOCYTE; NEOPLASM; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; STROMA CELL; TISSUE REPAIR; ANIMAL; CHEMISTRY; MOUSE; PHYSIOLOGY;

ANIMALS; C-REACTIVE PROTEIN; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MICE; SERUM AMYLOID P-COMPONENT;

EID: 84962858109     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.02.029     Document Type: Review

References (121)

1. R. Medzhitov Origin and physiological roles of inflammation Nature 454 2008 428 435
2. J.P. Casas, T. Shah, A.D. Hingorani, J. Danesh, and M.B. Pepys C-reactive protein and coronary heart disease: a critical review J Intern Med 264 2008 295 314
3. C. Garlanda, B. Bottazzi, A. Bastone, and A. Mantovani Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility Annu Rev Immunol 23 2005 337 366
4. J. Emsley, H.E. White, B.P. O'Hara, G. Oliva, N. Srinivasan, I.J. Tickle, and et al. Structure of pentameric human serum amyloid P component Nature 367 1994 338 345
5. A.R. Goodman, T. Cardozo, R. Abagyan, A. Altmeyer, H.G. Wisniewski, and J. Vilcek Long pentraxins: an emerging group of proteins with diverse functions Cytokine Growth Factor Rev 7 1996 191 202
6. F. Breviario, E.M. d'Aniello, J. Golay, G. Peri, B. Bottazzi, A. Bairoch, and et al. Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component J Biol Chem 267 1992 22190 22197
7. Y. Martinez de la Torre, M. Fabbri, S. Jaillon, A. Bastone, M. Nebuloni, A. Vecchi, and et al. Evolution of the pentraxin family: the new entry PTX4 J Immunol 184 2010 5055 5064
8. K.J. Lei, T. Liu, G. Zon, E. Soravia, T.Y. Liu, and N.D. Goldman Genomic DNA sequence for human C-reactive protein J Biol Chem 260 1985 13377 13383
9. P. Woo, J.R. Korenberg, and A.S. Whitehead Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component J Biol Chem 260 1985 13384 13388
10. A.K. Shrive, G.M. Cheetham, D. Holden, D.A. Myles, W.G. Turnell, J.E. Volanakis, and et al. Three dimensional structure of human C-reactive protein Nat Struct Biol 3 1996 346 354
11. D. Thompson, M.B. Pepys, and S.P. Wood The physiological structure of human C-reactive protein and its complex with phosphocholine Structure 7 1999 169 177
12. H. Mikolajek, S.E. Kolstoe, V.E. Pye, P. Mangione, M.B. Pepys, and S.P. Wood Structural basis of ligand specificity in the human pentraxins, C-reactive protein and serum amyloid P component J Mol Recognit 24 2011 371 377
13. J. Lu, L.L. Marnell, K.D. Marjon, C. Mold, T.W. Du Clos, and P.D. Sun Structural recognition and functional activation of FcgammaR by innate pentraxins Nature 456 2008 989 992
14. J. Lu, K.D. Marjon, C. Mold, T.W. Du Clos, and P.D. Sun Pentraxins and Fc receptors Immunol Rev 250 2012 230 238
15. B. Bottazzi, A. Doni, C. Garlanda, and A. Mantovani An integrated view of humoral innate immunity: pentraxins as a paradigm Annu Rev Immunol 28 2010 157 183
16. I.K. Poon, M.D. Hulett, and C.R. Parish Molecular mechanisms of late apoptotic/necrotic cell clearance Cell Death Differ 17 2010 381 397
17. M.B. Pepys, and G.M. Hirschfield C-reactive protein: a critical update J Clin Invest 111 2003 1805 1812
18. M.B. Pepys C-reactive protein and the acute phase response Nature 296 1982 12
19. M. Bijl, H. Bootsma, Y. Van Der Geld, P.C. Limburg, C.G. Kallenberg, and M.H. Van Rijswijk Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction Ann Rheum Dis 63 2004 831 835
20. A. Altmeyer, L. Klampfer, A.R. Goodman, and J. Vilcek Promoter structure and transcriptional activation of the murine TSG-14 gene encoding a tumor necrosis factor/interleukin-1-inducible pentraxin protein J Biol Chem 270 1995 25584 25590
21. A. Basile, A. Sica, E. d'Aniello, F. Breviario, G. Garrido, M. Castellano, and et al. Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation J Biol Chem 272 1997 8172 8178
22. F. Moalli, S. Jaillon, A. Inforzato, M. Sironi, B. Bottazzi, A. Mantovani, and et al. Pathogen recognition by the long pentraxin PTX3 J Biomed Biotechnol 2011 2011 830421
23. M. Presta, M. Camozzi, G. Salvatori, and M. Rusnati Role of the soluble pattern recognition receptor PTX3 in vascular biology J Cell Mol Med 11 2007 723 738
24. G.D. Norata, P. Marchesi, A. Pirillo, P. Uboldi, G. Chiesa, V. Maina, and et al. Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells Arterioscler Thromb Vasc Biol 28 2008 925 931
25. M. Sironi, A. Conti, S. Bernasconi, A.M. Fra, F. Pasqualini, M. Nebuloni, and et al. Generation and characterization of a mouse lymphatic endothelial cell line Cell Tissue Res 325 2006 91 100
26. S. Jaillon, G. Peri, Y. Delneste, I. Fremaux, A. Doni, F. Moalli, and et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps J Exp Med 204 2007 793 804
27. D.G. Craig, P. Lee, E.A. Pryde, S.W. Walker, G.J. Beckett, P.C. Hayes, and et al. Elevated levels of the long pentraxin 3 in paracetamol-induced human acute liver injury Eur J Gastroenterol Hepatol 25 2013 359 367
28. A. Doni, T. Musso, D. Morone, A. Bastone, V. Zambelli, M. Sironi, and et al. An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode J Exp Med 212 2015 905 925
29. A. Doni, M. Michela, B. Bottazzi, G. Peri, S. Valentino, N. Polentarutti, and et al. Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN-gamma J Leukoc Biol 79 2006 797 802
30. A. Doni, G. Mantovani, C. Porta, J. Tuckermann, H.M. Reichardt, A. Kleiman, and et al. Cell-specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and non-hematopoietic cells J Biol Chem 283 2008 29983 29992
31. B. Bottazzi, V. Vouret-Craviari, A. Bastone, L. De Gioia, C. Matteucci, G. Peri, and et al. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component J Biol Chem 272 1997 32817 32823
32. A. Inforzato, C. Baldock, T.A. Jowitt, D.F. Holmes, R. Lindstedt, M. Marcellini, and et al. The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2 J Biol Chem 285 2010 17681 17692
33. M. Introna, V.V. Alles, M. Castellano, G. Picardi, L. De Gioia, B. Bottazzai, and et al. Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites Blood 87 1996 1862 1872
34. A. Inforzato, G. Peri, A. Doni, C. Garlanda, A. Mantovani, A. Bastone, and et al. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation Biochemistry (Mosc) 45 2006 11540 11551
35. L. Deban, H. Jarva, M.J. Lehtinen, B. Bottazzi, A. Bastone, A. Doni, and et al. Binding of the long pentraxin PTX3 to Factor H: Interacting domains and function in the regulation of complement activation J Immunol 181 2008 8433 8440
36. E. Gout, C. Moriscot, A. Doni, C. Dumestre-Perard, M. Lacroix, J. Perard, and et al. M-ficolin interacts with the long pentraxin PTX3: a novel case of cross-talk between soluble pattern-recognition molecules J Immunol 186 2011 5815 5822
37. P.C. Reading, S. Bozza, B. Gilbertson, M. Tate, S. Moretti, E.R. Job, and et al. Antiviral activity of the long chain pentraxin PTX3 against influenza viruses J Immunol 180 2008 3391 3398
38. L. Deban, R. Castro Russo, M. Sironi, F. Moalli, M. Scanziani, V. Zambelli, and et al. Regulation of leukocyte recruitment by the long pentraxin PTX3 Nat Immunol 11 2010 328 334
39. E. Ievoli, R. Lindstedt, A. Inforzato, A. Camaioni, F. Palone, A.J. Day, and et al. Implication of the oligomeric state of the N-terminal PTX3 domain in cumulus matrix assembly Matrix Biol 30 2011 330 337
40. D. Stibenz, M. Grafe, N. Debus, M. Hasbach, I. Bahr, K. Graf, and et al. Binding of human serum amyloid P componentto L-selectin Eur J Immunol 36 2006 446 456
41. M. Lech, C. Rommele, R. Grobmayr, H. Eka Susanti, O.P. Kulkarni, S. Wang, and et al. Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury Kidney Int 83 2013 647 661
42. A. Inforzato, B. Bottazzi, C. Garlanda, S. Valentino, and A. Mantovani Pentraxins in humoral innate immunity Adv Exp Med Biol 946 2012 1 20
43. A.J. Nauta, M.R. Daha, C. van Kooten, and A. Roos Recognition and clearance of apoptotic cells: a role for complement and pentraxins Trends Immunol 24 2003 148 154
44. P.M. Ng, A. Le Saux, C.M. Lee, N.S. Tan, J. Lu, S. Thiel, and et al. C-reactive protein collaborates with plasma lectins to boost immune response against bacteria EMBO J 26 2007 3431 3440
45. D. Gershov, S. Kim, N. Brot, and K.B. Elkon C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity J Exp Med 192 2000 1353 1364
46. R. Gill, J.A. Kemp, C. Sabin, and M.B. Pepys Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats J Cereb Blood Flow Metab 24 2004 1214 1218
47. M.B. Pepys, J.R. Gallimore, J. Lloyd, Z. Li, D. Graham, G.W. Taylor, and et al. Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use J Immunol Methods 384 2012 92 102
48. H. Jarva, T.S. Jokiranta, J. Hellwage, P.F. Zipfel, and S. Meri Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11 J Immunol 163 1999 3957 3962
49. A.I. Okemefuna, R. Nan, A. Miller, J. Gor, and S.J. Perkins Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations J Biol Chem 285 2010 1053 1065
50. A.P. Sjoberg, L.A. Trouw, F.D. McGrath, C.E. Hack, and A.M. Blom Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding protein J Immunol 176 2006 7612 7620
51. P. Garcia de Frutos, Y. Hardig, and B. Dahlback Serum amyloid P component binding to C4b-binding protein J Biol Chem 270 1995 26950 26955
52. A. Kopp, M. Hebecker, E. Svobodova, and M. Jozsi Factor h: a complement regulator in health and disease, and a mediator of cellular interactions Biomolecules 2 2012 46 75
53. A.J. Nauta, B. Bottazzi, A. Mantovani, G. Salvatori, U. Kishore, W.J. Schwaeble, and et al. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q Eur J Immunol 33 2003 465 473
54. I. Bally, S. Ancelet, C. Moriscot, F. Gonnet, A. Mantovani, R. Daniel, and et al. Expression of recombinant human complement C1q allows identification of the C1r/C1s-binding sites Proc Natl Acad Sci U S A 110 2013 8650 8655
55. Y.J. Ma, A. Doni, T. Hummelshoj, C. Honore, A. Bastone, A. Mantovani, and et al. Synergy between ficolin-2 and PTX3 boost innate immune recognition and complement deposition J Biol Chem 284 2009 28263 28275
56. Y.J. Ma, A. Doni, M.O. Skjoedt, C. Honore, M. Arendrup, A. Mantovani, and et al. Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system J Biol Chem 286 2011 3405 3417
57. F. Moalli, A. Doni, L. Deban, T. Zelante, S. Zagarella, B. Bottazzi, and et al. Role of complement and Fc{gamma} receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus Blood 116 2010 5170 5180
58. A. Braunschweig, and M. Jozsi Human pentraxin 3 binds to the complement regulator c4b-binding protein PLoS One 6 2011 e23991
59. A. Kopp, S. Strobel, A. Tortajada, S. Rodriguez de Cordoba, P. Sanchez-Corral, Z. Prohaszka, and et al. Atypical hemolytic uremic syndrome-associated variants and autoantibodies impair binding of factor h and factor h-related protein 1 to pentraxin 3 J Immunol 189 2012 1858 1867
60. E. Bonavita, S. Gentile, M. Rubino, V. Maina, R. Papait, P. Kunderfranco, and et al. PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer Cell 160 2015 700 714
61. J. Lu, K.D. Marjon, L.L. Marnell, R. Wang, C. Mold, T.W. Du Clos, and et al. Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein Proc Natl Acad Sci U S A 108 2011 4974 4979
62. A. Inforzato, A. Doni, I. Barajon, R. Leone, C. Garlanda, B. Bottazzi, and et al. PTX3 as a paradigm for the interaction of pentraxins with the complement system Semin Immunol 25 2013 79 85
63. A. Agrawal, P.P. Singh, B. Bottazzi, C. Garlanda, and A. Mantovani Pattern recognition by pentraxins Adv Exp Med Biol 653 2009 98 116
64. J. Yuste, M. Botto, S.E. Bottoms, and J.S. Brown Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae PLoS Pathog 3 2007 1208 1219
65. M. Noursadeghi, M.C. Bickerstaff, J.R. Gallimore, J. Herbert, J. Cohen, and M.B. Pepys Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen Proc Natl Acad Sci U S A 97 2000 14584 14589
66. G.D. Armstrong, G.L. Mulvey, P. Marcato, T.P. Griener, M.C. Kahan, G.A. Tennent, and et al. Human serum amyloid P component protects against Escherichia coli O157:H7 Shiga toxin 2 in vivo: therapeutic implications for hemolytic-uremic syndrome J Infect Dis 193 2006 1120 1124
67. R. Wiest, M. Lawson, and M. Geuking Pathological bacterial translocation in liver cirrhosis J Hepatol 60 2014 197 209
68. O. Saitoh, K. Sugi, K. Lojima, H. Matsumoto, K. Nakagawa, M. Kayazawa, and et al. Increased prevalence of intestinal inflammation in patients with liver cirrhosis World J Gastroenterol 5 1999 391 396
69. C. Garlanda, E. Hirsch, S. Bozza, A. Salustri, M. De Acetis, R. Nota, and et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response Nature 420 2002 182 186
70. E.R. Job, Y.M. Deng, M.D. Tate, B. Bottazzi, E.C. Crouch, M.M. Dean, and et al. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collection and pentraxin superfamilies J Immunol 185 2010 4284 4291
71. S. Jaillon, G. Mancuso, Y. Hamon, C. Beauvillain, V. Cotici, A. Midiri, and et al. Prototypic long pentraxin PTX3 is present in breast milk, spreads in tissues, and protects neonate mice from Pseudomonas aeruginosa lung infection J Immunol 191 2013 1873 1882
72. S. Jaillon, F. Moalli, B. Ragnarsdottir, E. Bonavita, M. Puthia, F. Riva, and et al. The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection Immunity 40 2014 621 632
73. B. Bottazzi, L. Santini, S. Savino, M.M. Giuliani, A.I. Duenas Diez, G. Mancuso, and et al. Recognition of Neisseria meningitidis by the long pentraxin PTX3 and its role as an endogenous adjuvant PLoS One 10 2015 e0120807
74. E.R. Job, B. Bottazzi, K.R. Short, Y.M. Deng, A. Mantovani, A.G. Brooks, and et al. A single amino acid substitution in the hemagglutinin of H3N2 subtype influenza A viruses is associated with resistance to the long pentraxin PTX3 and enhanced virulence in mice J Immunol 192 2014 271 281
75. S.S. Foo, W. Chen, A. Taylor, K.C. Sheng, X. Yu, T.S. Teng, and et al. Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation PLoS Pathog 11 2015 e1004649
76. R. Olesen, C. Wejse, D.R. Velez, C. Bisseye, M. Sodemann, P. Aaby, and et al. DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans Genes Immun 8 2007 456 467
77. M. Chiarini, C. Sabelli, P. Melotti, C. Garlanda, G. Savoldi, C. Mazza, and et al. PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients Genes Immun 11 2010 665 670
78. C. Cunha, F. Aversa, J.F. Lacerda, A. Busca, O. Kurzai, M. Grube, and et al. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation N Engl J Med 370 2014 421 432
79. A. Wojtowicz, T.D. Lecompte, S. Bibert, O. Manuel, S. Rueger, C. Berger, and et al. PTX3 polymorphisms and invasive mold infections after solid organ transplant Clin Infect Dis 61 2015 619 622
80. E. Barbati, C. Specchia, M. Villella, M.L. Rossi, S. Barlera, B. Bottazzi, and et al. Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels PLoS One 7 2012 e53030
81. K. Bodin, S. Ellmerich, M.C. Kahan, G.A. Tennent, A. Loesch, J.A. Gilbertson, and et al. Antibodies to human serum amyloid P component eliminate visceral amyloid deposits Nature 468 2010 93 97
82. D.B. Richards, L.M. Cookson, A.C. Berges, S.V. Barton, T. Lane, J.M. Ritter, and et al. Therapeutic clearance of amyloid by antibodies to serum amyloid P component N Engl J Med 373 2015 1106 1114
83. A. Salustri, C. Garlanda, E. Hirsch, M. De Acetis, A. Maccagno, B. Bottazzi, and et al. PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization Development 131 2004 1577 1586
84. C. Fulop, S. Szanto, D. Mukhopadhyay, T. Bardos, R.V. Kamath, M.S. Rugg, and et al. Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice Development 130 2003 2253 2261
85. L. Scarchilli, A. Camaioni, B. Bottazzi, V. Negri, A. Doni, L. Deban, and et al. PTX3 interacts with inter-{alpha}-trypsin inhibitor: implications for hyaluronan organization and cumulus oophorus expansion J Biol Chem 282 2007 30161 30170
86. D. Pilling, and R.H. Gomer Persistent lung inflammation and fibrosis in serum amyloid P component (APCs-/-) knockout mice PLoS One 9 2014 e93730
87. N. Cox, D. Pilling, and R.H. Gomer Serum amyloid P: a systemic regulator of the innate immune response J Leukoc Biol 96 2014 739 743
88. M.R. Dillingh, B. van den Blink, M. Moerland, M.G. van Dongen, M. Levi, A. Kleinjan, and et al. Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis Pulm Pharmacol Ther 26 2013 672 676
89. N. Cox, D. Pilling, and R.H. Gomer DC-SIGN activation mediates the differential effects of SAP and CRP on the innate immune system and inhibits fibrosis in mice Proc Natl Acad Sci U S A 112 2015 8385 8390
90. P. Stal Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance World J Gastroenterol 21 2015 11077 11087
91. S. Boga, A.R. Koksal, H. Alkim, M.B. Yilmaz Ozguven, M. Bayram, M. Ergun, and et al. Plasma pentraxin 3 differentiates nonalcoholic steatohepatitis (NASH) from non-NASH Metab Syndr Relat Disord 13 2015 393 399
92. M. Yoneda, H. Mawatari, K. Fujita, H. Iida, K. Yonemitsu, S. Kato, and et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH J Gastroenterol 42 2007 573 582
93. M. Yoneda, T. Uchiyama, S. Kato, H. Endo, K. Fujita, K. Yoneda, and et al. Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH) BMC Gastroenterol 8 2008 53
94. I. Maleki, A. Rastgar, V. Hosseini, T. Taghvaei, A. Rafiei, M. Barzin, and et al. High sensitive CRP and pentraxine 3 as noninvasive biomarkers of nonalcoholic fatty liver disease Eur Rev Med Pharmacol Sci 18 2014 1583 1590
95. D. Pilling, N. Cox, V. Vakil, J.S. Verbeek, and R.H. Gomer The long pentraxin PTX3 promotes fibrocyte differentiation PLoS One 10 2015 e0119709
96. V. Calvaruso, S. Maimone, A. Gatt, E. Tuddenham, M. Thursz, M. Pinzani, and et al. Coagulation and fibrosis in chronic liver disease Gut 57 2008 1722 1727
97. J.F. Pohl, H. Melin-Aldana, G. Sabla, J.L. Degen, and J.A. Bezerra Plasminogen deficiency leads to impaired lobular reorganization and matrix accumulation after chronic liver injury Am J Pathol 159 2001 2179 2186
98. T.H. Bugge, K.W. Kombrinck, M.J. Flick, C.C. Daugherty, M.J. Danton, and J.L. Degen Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency Cell 87 1996 709 719
99. B. Engelmann, and S. Massberg Thrombosis as an intravascular effector of innate immunity Nat Rev Immunol 13 2013 34 45
100. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
101. L. Guo, S. Liu, S. Zhang, Q. Chen, M. Zhang, P. Quan, and et al. C-reactive protein and risk of breast cancer: a systematic review and meta-analysis Sci Rep 5 2015 10508
102. K. Heikkilä, R. Harris, G. Lowe, A. Rumley, J. Yarnell, J. Gallacher, and et al. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis Cancer Causes Control 20 2009 15 26
103. S. Kondo, H. Ueno, H. Hosoi, J. Hashimoto, C. Morizane, F. Koizumi, and et al. Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma Br J Cancer 109 2013 739 746
104. C. Morizane, T. Okusaka, S. Morita, K. Tanaka, H. Ueno, S. Kondo, and et al. Construction and validation of a prognostic index for patients with metastatic pancreatic adenocarcinoma Pancreas 40 2011 415 421
105. E.M. Poole, I.-M. Lee, P.M. Ridker, J.E. Buring, S.E. Hankinson, and S.S. Tworoger A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer Am J Epidemiol 178 2013 1256 1264
106. S. Mitsunaga, M. Ikeda, S. Shimizu, I. Ohno, H. Takahashi, H. Okuyama, and et al. C-reactive protein level is an indicator of the aggressiveness of advanced pancreatic cancer Pancreas 45 2016 110 116
107. B. Choi, E.J. Lee, D.H. Song, S.C. Yoon, Y.H. Chung, Y. Jang, and et al. Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function Oncotarget 5 2014 481 492
108. E.P. Diamandis, L. Goodglick, C. Planque, and M.D. Thornquist Pentraxin-3 is a novel biomarker of lung carcinoma Clin Cancer Res 17 2011 2395 2399
109. G. Germano, R. Frapolli, M. Simone, M. Tavecchio, E. Erba, S. Pesce, and et al. Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells Cancer Res 70 2010 2235 2244
110. M. Infante, P. Allavena, C. Garlanda, M. Nebuloni, E. Morenghi, D. Rahal, and et al. Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients Int J Cancer 138 2016 983 991
111. G. Stallone, L. Cormio, G.S. Netti, B. Infante, O. Selvaggio, G.D. Fino, and et al. Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer Cancer Res 74 2014 4230 4238
112. R.W. Tothill, A.V. Tinker, J. George, R. Brown, S.B. Fox, S. Lade, and et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome Clin Cancer Res 14 2008 5198 5208
113. R.F. Carmo, D. Aroucha, L.R. Vasconcelos, L.M. Pereira, P. Moura, and M.S. Cavalcanti Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV J Viral Hepat 23 2015 116 122
114. J.X. Wang, Y.L. He, S.T. Zhu, S. Yang, and S.T. Zhang Aberrant methylation of the 3q25 tumor suppressor gene PTX3 in human esophageal squamous cell carcinoma World J Gastroenterol 17 2011 4225 4230
115. R. Ronca, A. Giacomini, E. Di Salle, D. Coltrini, K. Pagano, L. Ragona, and et al. Long-Pentraxin 3 derivative as a small-molecule FGF trap for cancer therapy Cancer Cell 28 2015 225 239
116. R. Ronca, E. Di Salle, A. Giacomini, D. Leali, P. Alessi, D. Coltrini, and et al. Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells Mol Cancer Ther 12 2013 2760 2771
117. M. Rusnati, M. Camozzi, E. Moroni, B. Bottazzi, G. Peri, S. Indraccolo, and et al. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis Blood 104 2004 92 99
118. W.C. Chang, S.L. Wu, W.C. Huang, J.Y. Hsu, S.H. Chan, J.M. Wang, and et al. PTX3 gene activation in EGF-induced head and neck cancer cell metastasis Oncotarget 6 2015 7741 7757
119. B. Choi, E.J. Lee, Y.S. Park, S.M. Kim, E.Y. Kim, Y. Song, and et al. Pentraxin-3 silencing suppresses gastric cancer-related inflammation by inhibiting chemotactic migration of macrophages Anticancer Res 35 2015 2663 2668
120. A. Bartolini, D. Di Paolo, A. Noghero, D. Murgia, A.R. Sementa, M. Cilli, and et al. The neuronal pentraxin-2 pathway is an unrecognized target in human neuroblastoma, which also offers prognostic value in patients Cancer Res 75 2015 4265 4271
121. C. Zhou, Y. Qin, Z. Xie, J. Zhang, M. Yang, S. Li, and et al. NPTX1 is a novel epigenetic regulation gene and associated with prognosis in lung cancer Biochem Biophys Res Commun 458 2015 381 386